NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink Healthcare Solutions, the creator of Advantage SMART Practice®, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), will showcase its ASC Advantage™ all-in-one solution at Becker’s ASC 26th Annual Meeting from October 24-25, 2019 in Chicago, IL.
Designed to maximize efficiencies and improve profitability, Advantage uses real-time data to automate tasks and streamline patient flow. Features include:
Designed to maximize efficiencies and improve profitability, an all-in-one solution, Advantage includes EHR, patient registration, inventory management, preference cards, case scheduling, and lab and pathology integration. The company also provides an expert revenue cycle management service for its clients. Advantage is 2015 ONC Certified for MIPS and is used by more than 20,000 providers in over 4,700 locations, 60 ASCs, and 19 universities and colleges.
Attendees at Becker’s can demo ASC Advantage at booth 49S.
About Compulink Healthcare Solutions
A leader in specialty-specific, all-in-one EHR and Practice Management solutions for 34 years, Compulink’s Advantage SMART Practice® uses artificial intelligence to improve clinical and financial results. Designed to maximize your time while seeing patients, Advantage includes everything you need to optimize workflow including EHR, PM, ASC, patient engagement, and RCM.
Contacts
Compulink Healthcare Solutions
Mary Ann Fitzhugh
p. 800.456.4522
e. press@compulinkadvantage.com
Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash. (March…
DUBLIN--(BUSINESS WIRE)--The "Global Medical Device Connectivity Market: Analysis By Product & Services, By Technology, By…
VANCOUVER, WA / ACCESSWIRE / March 22, 2024 / At just eight years old, Zeke…
GOTHENBURG, SWEDEN / ACCESSWIRE / March 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB…
OCALA, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or…
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…